| PERIOD ENDING | 29-Jul-09 | 29-Apr-09 | 28-Jan-09 | 29-Oct-08 | | Total Revenue | 2,467,923 | 2,537,757 | 2,414,576 | 2,612,541 | | Cost of Revenue | 1,593,776 | 1,663,445 | 1,560,104 | 1,691,826 | | | Gross Profit | 874,147 | 874,312 | 854,472 | 920,715 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 508,178 | 541,083 | 472,662 | 534,366 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 365,969 | 333,229 | 381,810 | 386,349 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23,244 | 9,656 | 41,697 | 87,426 | | Earnings Before Interest And Taxes | 113,613 | 342,885 | 423,507 | 473,775 | | Interest Expense | 82,989 | 85,121 | 95,931 | 83,978 | | Income Before Tax | 30,624 | 257,764 | 327,576 | 389,797 | | Income Tax Expense | 87,132 | 82,629 | 85,313 | 113,087 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 219,092 | 175,135 | 242,263 | 276,710 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 219,092 | 175,135 | 242,263 | 276,710 | | Preferred Stock And Other Adjustments | (6,528) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $212,564 | $175,135 | $242,263 | $276,710 |
|
2.03% Nasdaq 
Income Statement
